These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6126724)

  • 21. Fatal encephalitis apparently due to rabies. Occurrence after treatment with human diploid cell vaccine but not rabies immune globulin.
    Devriendt J; Staroukine M; Costy F; Vanderhaeghen JJ
    JAMA; 1982 Nov; 248(18):2304-6. PubMed ID: 7131683
    [No Abstract]   [Full Text] [Related]  

  • 22. Leads from the MMWR. Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine--Thailand.
    JAMA; 1988 Jan; 259(1):25-6. PubMed ID: 3334758
    [No Abstract]   [Full Text] [Related]  

  • 23. [Efficacy of the administration of serum amd vaccine for the antirabies treatment of experimentally-infected sheep].
    Soria Baltazar R; Blancou J
    Rev Sci Tech; 1995 Sep; 14(3):691-710. PubMed ID: 8593402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective antibodies after vaccination with human diploid cell rabies vaccine.
    Wasi C; Chaiprasithikul P; Thongcharoen P; Rungpitarungsi V; Tharachan C; Likanontsakul S
    Asian Pac J Allergy Immunol; 1983 Dec; 1(2):125-30. PubMed ID: 6681004
    [No Abstract]   [Full Text] [Related]  

  • 25. Rhesus diploid rabies vaccine (adsorbed): a new rabies vaccine using FRhL-2 cells.
    Burgoyne GH; Kajiya KD; Brown DW; Mitchell JR
    J Infect Dis; 1985 Jul; 152(1):204-10. PubMed ID: 4008986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post exposure human-prophylaxis for rabies in developing countries.
    Onyemelukwe GC
    Afr J Med Med Sci; 1992 Dec; 21(2):1-12. PubMed ID: 1308073
    [No Abstract]   [Full Text] [Related]  

  • 27. Human diploid-cell rabies vaccine: efficacy of four doses.
    Hasbahceci M; Kiyan M; Eyol E; Ewalt LC; Lodmell DL
    Lancet; 1996 Apr; 347(9006):976-7. PubMed ID: 8598794
    [No Abstract]   [Full Text] [Related]  

  • 28. Rabies antibody titers in vaccinees: protection, failure and prospects.
    Dutta JK; Pradhan SC; Dutta TK
    Int J Clin Pharmacol Ther Toxicol; 1992 Mar; 30(3):107-12. PubMed ID: 1506120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early antibody responses to rabies post-exposure vaccine regimens.
    Suntharasamai P; Warrell MJ; Warrell DA; Chanthavanich P; Looareesuwan S; Supapochana A; Phanuphak P; Jittapalapongsa S; Yager PA; Baer GM
    Am J Trop Med Hyg; 1987 Jan; 36(1):160-5. PubMed ID: 3812881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postexposure rabies prophylaxis with human rabies immune globulin.
    Hattwick MA; Rubin RH; Music S; Sikes RK; Smith JS; Gregg MB
    JAMA; 1974 Jan; 227(4):407-10. PubMed ID: 4859675
    [No Abstract]   [Full Text] [Related]  

  • 31. Intradermal use of human diploid cell vaccine for preexposure rabies immunizations.
    Dreesen DW; Sumner JW; Brown J; Kemp DT
    J Am Vet Med Assoc; 1982 Dec; 181(12):1519-23. PubMed ID: 7161170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention and treatment of rabies in human beings (author's transl)].
    Paccaud MF
    Schweiz Rundsch Med Prax; 1978 Jan; 67(2):41-7. PubMed ID: 619349
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intradermal administration of HDC vaccine in the immunization of people against rabies].
    Svjetlicić M; Ljubicić M; Baklaić Z; Smerdel S; Vodopija I
    Lijec Vjesn; 1984 Sep; 106(9):379-80. PubMed ID: 6503605
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
    Schumacher CL; Dietzschold B; Ertl HC; Niu HS; Rupprecht CE; Koprowski H
    J Clin Invest; 1989 Sep; 84(3):971-5. PubMed ID: 2760222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretreatment antibody titers in repeated rabies prophylaxis.
    Lutwick LI; Shanley JD
    JAMA; 1980 Aug; 244(7):691. PubMed ID: 7392170
    [No Abstract]   [Full Text] [Related]  

  • 37. Rabies virus and the problems of rabies vaccination in man.
    Crick J; Brown F
    Trans R Soc Trop Med Hyg; 1976; 70(3):196-201. PubMed ID: 790671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response achieved by different rabies prophylaxis methods.
    Tulek N; Senocak H; Yetkin A; Un H; Aylan O
    Int J Infect Dis; 2006 Jan; 10(1):87-8. PubMed ID: 16242985
    [No Abstract]   [Full Text] [Related]  

  • 39. Rabies postexposure prophylaxis in the United States: Opportunities to improve access, coordination, and delivery.
    Howington GT; Nguyen HB; Bookstaver PB; Akpunonu P; Swan JT
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009461. PubMed ID: 34264942
    [No Abstract]   [Full Text] [Related]  

  • 40. Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin.
    Wilde H; Chomchey P; Punyaratabandhu P; Phanupak P; Chutivongse S
    Bull World Health Organ; 1989; 67(6):731-6. PubMed ID: 2633888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.